Husch Blackwell Debuts Psychedelics Practice Team

By Sam Reisman (March 16, 2022, 8:21 PM EDT) -- Husch Blackwell LLP has launched a legal practice group dedicated to helping clients navigate the emerging space of researching and developing medicines derived from federally controlled psychedelics.

The Kansas City-headquartered firm on Tuesday announced the debut of its psychedelics and emerging therapies group, which will be under the leadership of product liability litigators Kimberly Chew, Karen Luong and Natasha Sumner.

The California-based trio of senior counsel attorneys all came on board last April as part of a West Coast-based team of 21 litigators who joined Husch Blackwell from Dentons and opened offices in the Bay Area and Los Angeles.

The group's debut...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!